Clinical Trials Directory

Trials / Completed

CompletedNCT00841152

Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute

A National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone Defects

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Turku University Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to perform a head-to-head comparison of two synthetic ceramic bone graft substitutes, bioactive glass (BAG) and beta-tricalcium phosphate (TCP), in filling of contained bone defects following surgical evacuation of benign bone tumor or tumor-like conditions. Based on the investigators' previous preclinical research and an ongoing single-center randomized clinical trial on bioactive glass filling, the investigators expect BAG filling to be more efficient compared to TCP in promotion of defect healing and functional recovery after surgery.

Detailed description

This study is designed to perform a head-to-head comparison of two synthetic ceramic bone graft substitutes, bioactive glass (BAG) and beta-tricalcium phosphate (TCP), in filling of contained bone defects following surgical evacuation of benign bone tumor or tumor-like conditions. Small metacarpal and phalangeal enchondromas (Stratum I) and large long-bone lesions (Stratum II) will be evaluated separately. Aside with the head-to-head comparison of the two synthetic bone graft substitutes, autologous bone graft (Stratum I) and allogeneic bone graft (Stratum II) will be used as the standard of care controls.

Conditions

Interventions

TypeNameDescription
DEVICEBioactive glassSurgical implantation
DEVICEBeta-tricalcium phosphate (ChronOs)Surgical implantation
PROCEDUREAutograftSurgical transplantation from iliac crest
PROCEDUREAllograft (frozen femoral head)Surgical transplantation

Timeline

Start date
2009-03-01
Primary completion
2014-02-01
Completion
2018-12-01
First posted
2009-02-11
Last updated
2021-03-16

Locations

5 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT00841152. Inclusion in this directory is not an endorsement.